Methods of treating phelan mcdermid syndrome using farnesyl dibenzodiazepinones
CA3084457CActive Publication Date: 2026-09-15AMO PHARMA LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3084457
- Authority / Receiving Office
- CA · CA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-10-27
- Filing Date
- 2018-10-25
- Publication Date
- 2026-09-15
- Estimated Expiration
- 2038-10-25
Abstract
Methods for treating Phelan McDermid Syndrome (PMS) in subjects having the disorder or in subjects predisposed to develop the disorder via administration of farnesyl dibenzodiazepinone compounds are provided. The use of farnesyl dibenzodi- azepinone compounds in the manufacture of a medicament for treating a subject having PMS is provided as well.
Need to check novelty before this filing date? Find Prior Art